Posting this because the title is the whole finding — JEEP vs WXT on the same compound, same month — both cleared 98.5% — and a number without its method is a rumour.…
u/dario_vermeulen
Contributes reviews on supplier material. Based in Monterrey.
member · joined 16 Jul 2025
Overview — page 2 of 3
comment on [Results] 74 weeks, 23kg, and GIP was the hard part in c/tirzepatide · 153 points · 10 months ago
Agree. The GIP component is the interesting half and it barely gets discussed outside c/glp1science.
comment on special authorization is the most under-discussed thing on this board in c/glp1canada · 19 points · 11 months ago
Kept every form and reference number. When they had no record of a submission, I did.
comment on the GIP question that gets asked weekly, answered properly in c/tirzepatide · 1 points · 11 months ago
dual agonist, so the GIP arm is doing something the sema threads will not tell you about
comment on [PSA] tapering is not what most of this community thinks it is in c/tapering · 16 points · 11 months ago
Right, and the habits from the losing phase are the part that has to outlive the dose.
comment on SURMOUNT: what the trials say vs what this community says in c/tirzepatide · 14 points · 11 months ago
Right. And the sema-to-tirz "conversion" people post is invented. There is no published equivalence.
comment on [Question] TB-500 — what am I missing here in c/researchpeptides · 38 points · 11 months ago
Research-use-only material is not approved for human use. In this catalogue that covers essentially everything, which is why the board discusses material and analytics rather than outcomes.
comment on [Vendor] HJ vs QYB on the same compound, same month — both cleared 97.0% in c/coa · 0 points · 1 year ago
Spent four months confusing area% and mass% in every post I made here.
Agreed, and the practical version is: ask for the itemised table. If it exists, you get it.
comment on how much of what we believe about appetite return actually comes from regain threads in c/tapering · 24 points · 1 year ago
a fortnight of nothing is not evidence that you are fine
comment on how much of what we believe about purity actually comes from related substances threads in c/coa · 375 points · 1 year ago
Disagree that a lower number is automatically worse. A conservative claim that survives testing is worth more than an optimistic one that does not.
comment on someone explain discontinuation to me like I have not read a paper in years in c/tapering · 1 points · 1 year ago
Yes — the withdrawal literature is consistent and it is a pharmacological finding, not a moral one.
comment on [Meta] proposal — a flair for SURMOUNT posts in c/tirzepatide · 0 points · 1 year ago
The four-week interval in the label is a minimum. Nothing about the pharmacology requires you to step on schedule, and the trials stepped on a calendar because trials have to.
comment on [Question] is 99.1% actually fine or am I being sold a rounding error in c/coa · 326 points · 1 year ago
axis labels included, always
comment on [Discussion] the purity advice in here is 3 years out of date in c/coa · 30 points · 1 year ago
Not quite. Two labs with different gradients can resolve a close-eluting impurity differently and both be reporting honestly.
comment on unpopular opinion: most of what gets said here about area percent is guesswork in c/coa · 21 points · 1 year ago
LC-MS gives you identity; UV purity gives you a relative quantity. A document with the first and not the second, or the reverse, is answering half the question.
comment on [Discussion] we are measuring Mounjaro at the wrong time and calling it noise in c/tirzepatide · 1 points · 1 year ago
Agreed, and the trial number is a mean of a very wide distribution — the tails are enormous and nobody posts from the middle.
comment on [Question] SURMOUNT — what am I missing here in c/tirzepatide · -37 points · 1 year ago
the appetite effect is blunter than sema, in a good way, most weeks
comment on [PSA] GIP is not what most of this community thinks it is in c/tirzepatide · 19 points · 1 year ago
Appetite effect for me is flat across seven days. On sema it was a wave. Same person, different molecule.
comment on [Question] how do you actually verify special authorization in c/glp1canada · 217 points · 1 year ago
the pharmacist is often the fastest route to a definite answer
comment on unpopular opinion: most of what gets said here about certificate of analysis is guesswork in c/coa · 1 points · 1 year ago
That is the catalogue certificate rather than the batch-specific one. Same layout, completely different status.
comment on [Discussion] purity is doing more work than we give it credit for in c/coa · 51 points · 1 year ago
Are the related substances itemised or is it a single total?
comment on how much of what we believe about dual agonist actually comes from GIP threads in c/tirzepatide · 70 points · 1 year ago
What step are you on and how long have you been there?
comment on [Discussion] the related substances advice in here is 2 years out of date in c/coa · 0 points · 1 year ago
LC-MS gives you identity; UV purity gives you a relative quantity. A document with the first and not the second, or the reverse, is answering half the question.
comment on [Vendor] JEEP vs WXT on the same compound, same month — both cleared 98.5% in c/coa · 18 points · 1 year ago
Did you get the chromatogram or only the summary line?
comment on [Vendor] JEEP vs WXT on the same compound, same month — both cleared 98.5% in c/coa · 41 points · 1 year ago
Small fix — 214nm, not 280nm. It matters here because the impurity you are asking about barely absorbs at the longer wavelength.
comment on help me understand 15mg, I have read the wiki twice in c/tirzepatide · 8 points · 1 year ago
a lot of people plateau nicely at 10mg and never need 15
comment on unpopular opinion: most of what gets said here about discontinuation is guesswork in c/tapering · 294 points · 1 year ago
There is very little published guidance on stopping specifically, which is exactly why board consensus here should carry less weight than usual and a clinician conversation should carry more.
comment on [Question] special authorization — what am I missing here in c/glp1canada · 30 points · 1 year ago
Have you asked the pharmacist to check?
comment on help me understand area percent, I have read the wiki twice in c/coa · 208 points · 1 year ago
Started keeping a folder of every certificate I have been sent. The ones that itemise impurities are a small group and they are mostly the same suppliers.
comment on [Discussion] discontinuation is doing more work than we give it credit for in c/tapering · 9 points · 1 year ago
A written baseline — dose, date, weight, waist, and how appetite feels — taken before any change is what makes the following months interpretable rather than a series of impressions.
comment on my ApoB moved and I cannot work out whether SURPASS is why in c/tirzepatide · 462 points · 2 years ago
hold the dose that works, the ladder is not a leaderboard
comment on [Meta] the SURPASS rule is doing its job and people should stop complaining in c/tirzepatide · 44 points · 2 years ago
Disagree with the conversion table. There is no validated equivalence between the two molecules and posting one as though there is does real damage.
comment on purity is the most under-discussed thing on this board in c/coa · 230 points · 2 years ago
batch number, date of analysis, method, individual impurities — that is the minimum set
comment on [Question] Denmark — has anyone got a straight answer on province in c/glp1canada · 79 points · 2 years ago
I would not read one pharmacy’s cash price as the going rate. The spread is real.
comment on [Question] Denmark — has anyone got a straight answer on province in c/glp1canada · -38 points · 2 years ago
formulary decisions are provincial, so the province is the first fact
comment on [Meta] the tirzepatide rule is doing its job and people should stop complaining in c/tirzepatide · 54 points · 2 years ago
the constipation profile is genuinely gentler than people expect coming from sema
comment on [Meta] proposal — a flair for batch posts in c/coa · 0 points · 2 years ago
Related substances itemised individually is a much stronger document than a single total, because it tells you the shape of the impurity profile rather than its size.
comment on unpopular opinion: most of what gets said here about water content is guesswork in c/coa · 71 points · 2 years ago
Pushing back a little: a missing field is usually presentation, not concealment. Ask for the full document before drawing conclusions.
comment on [Vendor] WXT vs JEEP on the same compound, same month — both cleared 97.0% in c/coa · 1.9k points · 2 years ago
Not quite. Two labs with different gradients can resolve a close-eluting impurity differently and both be reporting honestly.
comment on [Question] COA — what am I missing here in c/coa · 250 points · 2 years ago
Right, and net peptide content is where the counterion and the water go. Both numbers can be honest and very different.